The Lymphoma, Leukemia & Myeloma (LLM) Congress took place virtually, from 19 – 23 October 2021. This year's dynamic program included emerging data, innovative treatment methods, and a glimpse into the future of lymphoma, myeloma, and leukemia. More videos coming soon!
View all videos

LLM 2021

The Lymphoma, Leukemia & Myeloma Congress 2021
19–23 October 2021 | Virtual Meeting

7/ Follow us along during #ASH21 #ASH21_MSKMM for comments on different abstract! #MedTwitter @kordeneha1 @LesokhinMD @UrviShahMD @CarlynRTanMD @MalinHultcrantz Drs. Hassoun, Malilankody & Maclachlan not on twitter @sloan_kettering @ASH_hematology @HemOncFellows

@szusmani @SLentzsch @jmikhaelmd @asgemrecan @MM_Hub For resource limited countries where access to CART or Bites are not possible an effective combination for Lenalidomide refractory patients is Daratumumab plus Carfilzomib https://authors.elsevier.com/c/1eBN~5EIIgECBd

Zack Pemberton-Whiteley (@ZPWLC) of @LeukaemiaCareUK shares experiences of patients with chronic lymphocytic #Leukemia during the #COVID19 pandemic.

▶️Watch here: http://ow.ly/ZBUs50GZF3e

@iwCLL #iwCLL2021 #CLLsm #LEUsm #HemOnc

Ernst Holler of @uni_regensburg summarizes recent research on biomarkers and prognostication for #GvHD.

👉Watch here: http://ow.ly/MTig50GZEHP👈

@COSTEMCongress #COSTEM21 #GvHD #HemOnc

🏆 The Inaugural Pelotonia Impact Awards 🏆

Award 5️⃣ (the final award!) is the Pelotonia-Funded Researcher of the Year Award.

Let's cheer on our winner: Dr. Jennifer Woyach, a hematologist-oncologist at @OSUCCC_James 🎊

Load More...

LLM 2021

The Lymphoma, Leukemia & Myeloma Congress 2021
19–23 October 2021 | Virtual Meeting
The Lymphoma, Leukemia & Myeloma (LLM) Congress took place virtually, from 19 – 23 October 2021. This year's dynamic program included emerging data, innovative treatment methods, and a glimpse into the future of lymphoma, myeloma, and leukemia. More videos coming soon!
View all videos

7/ Follow us along during #ASH21 #ASH21_MSKMM for comments on different abstract! #MedTwitter @kordeneha1 @LesokhinMD @UrviShahMD @CarlynRTanMD @MalinHultcrantz Drs. Hassoun, Malilankody & Maclachlan not on twitter @sloan_kettering @ASH_hematology @HemOncFellows

@szusmani @SLentzsch @jmikhaelmd @asgemrecan @MM_Hub For resource limited countries where access to CART or Bites are not possible an effective combination for Lenalidomide refractory patients is Daratumumab plus Carfilzomib https://authors.elsevier.com/c/1eBN~5EIIgECBd

Zack Pemberton-Whiteley (@ZPWLC) of @LeukaemiaCareUK shares experiences of patients with chronic lymphocytic #Leukemia during the #COVID19 pandemic.

▶️Watch here: http://ow.ly/ZBUs50GZF3e

@iwCLL #iwCLL2021 #CLLsm #LEUsm #HemOnc

Ernst Holler of @uni_regensburg summarizes recent research on biomarkers and prognostication for #GvHD.

👉Watch here: http://ow.ly/MTig50GZEHP👈

@COSTEMCongress #COSTEM21 #GvHD #HemOnc

🏆 The Inaugural Pelotonia Impact Awards 🏆

Award 5️⃣ (the final award!) is the Pelotonia-Funded Researcher of the Year Award.

Let's cheer on our winner: Dr. Jennifer Woyach, a hematologist-oncologist at @OSUCCC_James 🎊

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter